JP2013018787A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013018787A5 JP2013018787A5 JP2012227416A JP2012227416A JP2013018787A5 JP 2013018787 A5 JP2013018787 A5 JP 2013018787A5 JP 2012227416 A JP2012227416 A JP 2012227416A JP 2012227416 A JP2012227416 A JP 2012227416A JP 2013018787 A5 JP2013018787 A5 JP 2013018787A5
- Authority
- JP
- Japan
- Prior art keywords
- administration
- period
- contraceptive
- interruption period
- woman
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Claims (14)
- 単相で柔軟に延長されたサイクルの投与方法により投与するための、20μｇのエチニルエストラジオール及び３mgのドロスピレノンを含んで成る女性用経口避妊剤であって、当該投与方法が、
（ａ）24日間の第一の投与期間にわたり、当該女性に当該避妊剤を毎日投与し、次に
（ｂ）96日間以下の第二投与期間にわたり、当該女性に当該避妊剤を毎日投与し、ここで当該第二投与期間の間に又は直後に当該避妊剤を投与しない３〜６日間の中断期間を設け、そして
（ｃ）前記中断期間の後、当該女性に当該避妊剤を、上記（ａ）及び（ｂ）に従って投与する、
ことを含んで成ることを特徴とする前記女性用経口避妊剤。 - 前記中断期間が４日間である、請求項１に記載の女性用経口避妊剤。
- 前記女性の必要に応じて、そして出血問題の不存在下で、前記中断期間が開始される、請求項１又は２に記載の女性用経口避妊剤。
- 許容できない出血の際に前記中断期間が開始される、請求項１又は２に記載の女性用経口避妊剤。
- 破綻出血の際に前記中断期間が開始される、請求項１又は２に記載の女性用経口避妊剤。
- 前記第二投与期間の直後に前記中断期間が開始される、請求項１又は２に記載の女性用経口避妊剤。
- 前記第二投与期間の長さが、前記第一投与期間と同じであるか又はそれより長い、請求項１〜６のいずれか１項に記載の女性用経口避妊剤。
- 女性用経口避妊剤の製造のためのエチニルエストラジオール及びドロスピレノンの使用において、当該女性用経口避妊剤が、単相で柔軟に延長されたサイクルの投与方法により投与するための、20μｇのエチニルエストラジオール及び３mgのドロスピレノンを含んで成る女性用経口避妊剤であって、当該投与方法が、
（ａ）24日間の第一の投与期間にわたり、当該女性に当該避妊剤を毎日投与し、次に
（ｂ）96日間以下の第二投与期間にわたり、当該女性に当該避妊剤を毎日投与し、ここで当該第二投与期間の間に又は直後に当該避妊剤を投与しない３〜６日間の中断期間を設け、そして
（ｃ）前記中断期間の後、当該女性に当該避妊剤を、上記（ａ）及び（ｂ）に従って投与する、
ことを含んで成ることを特徴とする前記の使用。 - 前記中断期間が４日間である、請求項８に記載の製造のための使用。
- 前記女性の必要に応じて、そして出血問題の不存在下で、前記中断期間が開始される、請求項８又は９に記載の製造のための使用。
- 許容できない出血の際に前記中断期間が開始される、請求項８又は９に記載の製造のための使用。
- 破綻出血の際に前記中断期間が開始される、請求項８又は９に記載の製造のための使用。
- 前記第二投与期間の直後に前記中断期間が開始される、請求項８又は９に記載の製造のための使用。
- 前記第二投与期間の長さが、前記第一投与期間と同じであるか又はそれより長い、請求項８〜13のいずれか１項に記載の製造のための使用。
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56644304P | 2004-04-30 | 2004-04-30 | |
| US60/566,443 | 2004-04-30 | ||
| US57502404P | 2004-05-28 | 2004-05-28 | |
| US60/575,024 | 2004-05-28 | ||
| US57719904P | 2004-06-07 | 2004-06-07 | |
| US60/577,199 | 2004-06-07 | ||
| US63838004P | 2004-12-27 | 2004-12-27 | |
| US60/638,380 | 2004-12-27 | ||
| US66006805P | 2005-03-10 | 2005-03-10 | |
| US60/660,068 | 2005-03-10 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007509994A Division JP2007535519A (ja) | 2004-04-30 | 2005-04-29 | 延長されたホルモン避妊法における破綻出血の管理 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015126043A Division JP6153967B2 (ja) | 2004-04-30 | 2015-06-23 | 延長されたホルモン避妊法における破綻出血の管理 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013018787A JP2013018787A (ja) | 2013-01-31 |
| JP2013018787A5 true JP2013018787A5 (ja) | 2014-01-16 |
| JP6134491B2 JP6134491B2 (ja) | 2017-05-24 |
Family
ID=35056905
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007509994A Withdrawn JP2007535519A (ja) | 2004-04-30 | 2005-04-29 | 延長されたホルモン避妊法における破綻出血の管理 |
| JP2012227416A Active JP6134491B2 (ja) | 2004-04-30 | 2012-10-12 | 延長されたホルモン避妊法における破綻出血の管理 |
| JP2015126043A Active JP6153967B2 (ja) | 2004-04-30 | 2015-06-23 | 延長されたホルモン避妊法における破綻出血の管理 |
| JP2016241318A Withdrawn JP2017048253A (ja) | 2004-04-30 | 2016-12-13 | 延長されたホルモン避妊法における破綻出血の管理 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007509994A Withdrawn JP2007535519A (ja) | 2004-04-30 | 2005-04-29 | 延長されたホルモン避妊法における破綻出血の管理 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015126043A Active JP6153967B2 (ja) | 2004-04-30 | 2015-06-23 | 延長されたホルモン避妊法における破綻出血の管理 |
| JP2016241318A Withdrawn JP2017048253A (ja) | 2004-04-30 | 2016-12-13 | 延長されたホルモン避妊法における破綻出血の管理 |
Country Status (29)
| Country | Link |
|---|---|
| US (3) | US8163721B2 (ja) |
| EP (1) | EP1747001B1 (ja) |
| JP (4) | JP2007535519A (ja) |
| KR (4) | KR20070004919A (ja) |
| CN (1) | CN103127156A (ja) |
| AR (1) | AR048722A1 (ja) |
| AU (1) | AU2005237255B2 (ja) |
| BR (1) | BRPI0510493A (ja) |
| CA (1) | CA2562296A1 (ja) |
| CR (1) | CR8709A (ja) |
| DK (1) | DK1747001T3 (ja) |
| EA (2) | EA031227B1 (ja) |
| EC (1) | ECSP066999A (ja) |
| ES (1) | ES2704999T3 (ja) |
| HU (1) | HUE041475T2 (ja) |
| IL (1) | IL178458A (ja) |
| LT (1) | LT1747001T (ja) |
| MX (1) | MXPA06012567A (ja) |
| MY (1) | MY151322A (ja) |
| NO (1) | NO341685B1 (ja) |
| NZ (1) | NZ586107A (ja) |
| PA (1) | PA8631801A1 (ja) |
| PE (1) | PE20060467A1 (ja) |
| SG (2) | SG152288A1 (ja) |
| SI (1) | SI1747001T1 (ja) |
| SV (1) | SV2006002100A (ja) |
| TW (1) | TWI374735B (ja) |
| UY (1) | UY28875A1 (ja) |
| WO (1) | WO2005105103A2 (ja) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020132801A1 (en) * | 2001-01-11 | 2002-09-19 | Schering Aktiengesellschaft | Drospirenone for hormone replacement therapy |
| MY151322A (en) | 2004-04-30 | 2014-05-15 | Bayer Ip Gmbh | Management of breakthrough bleeding in extended hormonal contraceptive regimens |
| US20070111975A1 (en) | 2004-10-07 | 2007-05-17 | Duramed Pharmaceuticals, Inc. | Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens |
| US20070088010A1 (en) * | 2005-10-17 | 2007-04-19 | Doris Huebler | Method of making a single-stage pharmaceutical preparation for oral therapy of dysfunctional uterine bleeding, containing ethinyl estradiol and dienogest |
| EP1977752A1 (de) * | 2007-03-01 | 2008-10-08 | Bayer Schering Pharma Aktiengesellschaft | Pharmazeutische Zubereitung zur Verminderung der Endometriose |
| DE102007011105A1 (de) * | 2007-03-02 | 2008-09-04 | Bayer Schering Pharma Aktiengesellschaft | Mineralcorticoid-Rezeptor-Antagonisten zur Behandlung von Endometriose |
| GB2475013A (en) * | 2008-09-16 | 2011-05-04 | Playtex Products Llc | Dosages for menstrual suppression, contraception, and hormone replacement therapy, and methods of administrating same |
| ES2734510T3 (es) | 2008-10-08 | 2019-12-10 | Agile Therapeutics Inc | Administración transdérmica |
| WO2010042610A1 (en) | 2008-10-08 | 2010-04-15 | Agile Therapeutics, Inc. | Transdermal delivery |
| EP2343979B1 (en) | 2008-10-08 | 2020-04-08 | Agile Therapeutics, Inc. | Transdermal delivery |
| WO2010111488A1 (en) | 2009-03-27 | 2010-09-30 | Agile Therapeutics, Inc. | Transdermal delivery |
| AR081670A1 (es) | 2010-06-29 | 2012-10-10 | Leon Farma Sa Lab | Composicion farmaceutica que comprende drospirenona y kit anticonceptivo |
| US10849857B2 (en) | 2010-07-28 | 2020-12-01 | Laboratorios Leon Farma Sa | Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same |
| US11351122B1 (en) | 2010-07-28 | 2022-06-07 | Laboratorios Leon Farma Sa | Synthetic progestogens and pharmaceutical compositions comprising the same |
| US9603860B2 (en) | 2010-07-28 | 2017-03-28 | Laboratorios Leon Farma Sa | Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same |
| EP2383279A1 (en) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
| ES2877186T3 (es) | 2015-06-18 | 2021-11-16 | Estetra Sprl | Comprimido orodispersable que contiene estetrol |
| LT3310346T (lt) | 2015-06-18 | 2021-06-10 | Estetra Sprl | Burnoje disperguojama tabletė, turinti estetrolio |
| GEP20217243B (en) | 2015-06-18 | 2021-04-26 | Sprl Estetra | Orodispersible dosage unit containing an estetrol component |
| TN2017000499A1 (en) | 2015-06-18 | 2019-04-12 | Mithra Pharmaceuticals S A | Orodispersible dosage unit containing an estetrol component |
| CN108025014B (zh) * | 2015-06-23 | 2021-10-22 | 莱昂实验室制药股份有限公司 | 用于过重女性患者的基于屈螺酮的避孕药 |
| KR20220144885A (ko) | 2016-08-05 | 2022-10-27 | 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 | 월경통 및 생리통의 관리방법 |
| IL300580A (en) | 2016-09-30 | 2023-04-01 | Takeda Pharmaceuticals Co | Methods for treating uterine fibroids and endometrial disease |
| JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
| TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5244096A (en) | 1988-04-22 | 1993-09-14 | Stoner Fred L | Preventive treatment kit against sexually transmitted disease |
| AU3473193A (en) | 1992-01-17 | 1993-08-03 | Procter & Gamble Company, The | Treatment for atherosclerosis |
| DE4344462C2 (de) | 1993-12-22 | 1996-02-01 | Schering Ag | Zusammensetzung für die Empfängnisverhütung |
| US5552394A (en) | 1994-07-22 | 1996-09-03 | The Medical College Of Hampton Roads | Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy |
| CN1186024C (zh) * | 1996-07-26 | 2005-01-26 | 惠氏公司 | 单阶段避孕方法和含有黄体酮和雌激素组合物的避孕药盒 |
| US6451778B1 (en) | 1996-07-26 | 2002-09-17 | Wyeth | Oral contraceptive |
| US5842441A (en) | 1996-08-26 | 1998-12-01 | Pharmalett Denmark A/S | Medicated and individualized treatment shampoo for dermatological disturbances of companion animals |
| US5898032A (en) * | 1997-06-23 | 1999-04-27 | Medical College Of Hampton Roads | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
| DE19739916C2 (de) * | 1997-09-11 | 2001-09-13 | Hesch Rolf Dieter | Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen |
| US6787531B1 (en) * | 1999-08-31 | 2004-09-07 | Schering Ag | Pharmaceutical composition for use as a contraceptive |
| JP4354667B2 (ja) | 1999-08-31 | 2009-10-28 | バイエル・シエーリング・ファーマ・アクチエンゲゼルシャフト | 避妊薬としての使用へのエチニルエストラジオールとドロスピレノンの医薬用組合せ |
| CO5271709A1 (es) | 2000-01-12 | 2003-04-30 | Pfizer Prod Inc | Composiciones y procedimientos para el y tratamiento de afecciones que responden a estrogenos |
| US6653298B2 (en) * | 2000-01-14 | 2003-11-25 | Sterix Limited | Composition |
| DE10045380A1 (de) * | 2000-09-14 | 2002-04-04 | Schering Ag | Verfahren zur Kontrazeption und dessen Darreichungsform |
| IL145876A0 (en) | 2000-10-17 | 2002-07-25 | Pfizer Prod Inc | Methods and kits for improving vascular health |
| US20020193356A1 (en) * | 2001-05-23 | 2002-12-19 | Van Beek Agatha Antonia Magdalena | Means and method for hormonal contraception |
| US20030018018A1 (en) | 2001-07-10 | 2003-01-23 | Medical College Of Hampton Roads | Ultra low dose oral contraceptives with sustained efficacy and induced amenorrhea |
| MY151322A (en) * | 2004-04-30 | 2014-05-15 | Bayer Ip Gmbh | Management of breakthrough bleeding in extended hormonal contraceptive regimens |
| US8501720B2 (en) | 2004-07-30 | 2013-08-06 | Bayer Pharma AG | Method for treatment of dysmenorrhea |
-
2005
- 2005-04-19 MY MYPI20051728 patent/MY151322A/en unknown
- 2005-04-27 UY UY28875A patent/UY28875A1/es active IP Right Grant
- 2005-04-29 AU AU2005237255A patent/AU2005237255B2/en active Active
- 2005-04-29 SG SG200902990-1A patent/SG152288A1/en unknown
- 2005-04-29 KR KR1020067022523A patent/KR20070004919A/ko not_active Application Discontinuation
- 2005-04-29 KR KR1020167035558A patent/KR20160150113A/ko not_active Application Discontinuation
- 2005-04-29 EA EA201200377A patent/EA031227B1/ru not_active IP Right Cessation
- 2005-04-29 EP EP05740127.5A patent/EP1747001B1/en active Active
- 2005-04-29 EA EA200601908A patent/EA016625B1/ru not_active IP Right Cessation
- 2005-04-29 TW TW094113795A patent/TWI374735B/zh active
- 2005-04-29 SI SI200532240T patent/SI1747001T1/sl unknown
- 2005-04-29 HU HUE05740127A patent/HUE041475T2/hu unknown
- 2005-04-29 JP JP2007509994A patent/JP2007535519A/ja not_active Withdrawn
- 2005-04-29 ES ES05740127T patent/ES2704999T3/es active Active
- 2005-04-29 DK DK05740127.5T patent/DK1747001T3/en active
- 2005-04-29 BR BRPI0510493-9A patent/BRPI0510493A/pt not_active Application Discontinuation
- 2005-04-29 LT LTEP05740127.5T patent/LT1747001T/lt unknown
- 2005-04-29 SV SV2005002100A patent/SV2006002100A/es unknown
- 2005-04-29 KR KR1020157012286A patent/KR101812160B1/ko active IP Right Grant
- 2005-04-29 NZ NZ586107A patent/NZ586107A/en unknown
- 2005-04-29 MX MXPA06012567A patent/MXPA06012567A/es active IP Right Grant
- 2005-04-29 SG SG10201701904TA patent/SG10201701904TA/en unknown
- 2005-04-29 WO PCT/EP2005/004777 patent/WO2005105103A2/en active Application Filing
- 2005-04-29 KR KR1020137001481A patent/KR20130022425A/ko not_active Application Discontinuation
- 2005-04-29 CA CA002562296A patent/CA2562296A1/en not_active Abandoned
- 2005-04-29 CN CN2012105794658A patent/CN103127156A/zh active Pending
- 2005-05-02 US US11/118,779 patent/US8163721B2/en active Active
- 2005-05-02 AR ARP050101738A patent/AR048722A1/es not_active Application Discontinuation
- 2005-05-03 PA PA20058631801A patent/PA8631801A1/es unknown
- 2005-05-03 PE PE2005000490A patent/PE20060467A1/es not_active Application Discontinuation
-
2006
- 2006-10-05 IL IL178458A patent/IL178458A/en active IP Right Grant
- 2006-10-25 CR CR8709A patent/CR8709A/es not_active Application Discontinuation
- 2006-11-13 EC EC2006006999A patent/ECSP066999A/es unknown
- 2006-11-28 NO NO20065499A patent/NO341685B1/no unknown
-
2012
- 2012-04-17 US US13/448,585 patent/US20120202779A1/en not_active Abandoned
- 2012-10-12 JP JP2012227416A patent/JP6134491B2/ja active Active
-
2015
- 2015-03-09 US US14/642,096 patent/US20150174142A1/en not_active Abandoned
- 2015-06-23 JP JP2015126043A patent/JP6153967B2/ja active Active
-
2016
- 2016-12-13 JP JP2016241318A patent/JP2017048253A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013018787A5 (ja) | ||
| JP2015187157A5 (ja) | ||
| JP2013529665A5 (ja) | ||
| AU2012293593A8 (en) | Use of estetrol as emergency contraceptive | |
| HRP20161437T1 (hr) | Postupak hitne kontracepcije | |
| MX2019005289A (es) | Composiciones de corticosteroides administradas oralmente. | |
| EA201201403A1 (ru) | Очень низкодозированные твердые пероральные лекарственные формы для гзт | |
| RS53876B1 (en) | PARENTERAL PHARMACEUTICAL FORM, WHICH RELEASES AROMATASE AND GESTAGEN BLOCKERS, FOR THE TREATMENT OF ENDOMETRIOSIS | |
| JP2010180236A5 (ja) | ||
| PE20080273A1 (es) | Composicion farmaceutica que contiene un progestageno, un estrogeno y un acido tetrahidrofolico | |
| JP2013517299A5 (ja) | ||
| JP2015155440A5 (ja) | ||
| BR112012033391A8 (pt) | kit contraceptivo, método contraceptivo para uma paciente do sexo feminino necessitando do mesmo e composição farmacêutica compreendendo drospirenova. | |
| JP2013231087A5 (ja) | ||
| WO2011156812A3 (en) | Intravaginal administration of misoprostol | |
| JP2018527305A5 (ja) | ||
| WO2014107730A3 (en) | Use of fatty acid niacin conjugates for treating diseases | |
| MD4563C1 (ro) | Produs de comicronizare cu conţinut de acetat de ulipristal | |
| PE20081895A1 (es) | Regimen anticonceptivo oral | |
| JP2013047269A5 (ja) | ||
| MY172530A (en) | Method for treating gynecological diseases | |
| JP2016522188A5 (ja) | ||
| MX2013008992A (es) | Composicion farmaceutica con agentes antiinflamatorios y proceso de produccion. | |
| PH12015502160A1 (en) | Use of specific carbohydrate systems during pregnancy for preventing fat accumulation in pregnant women | |
| TN2015000197A1 (en) | Use and application regimen of a pharmaceutical composition containing levonorgestrel and a cox inhibitor for on-demand contraception |